Related Experiment Video
Updated: Dec 28, 2025

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
Dopamine and Noradrenaline in the Brain; Overlapping or Dissociate Functions?
Yadollah Ranjbar-Slamloo1, Zeinab Fazlali2
1Eccles Institute of Neuroscience, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
Dopamine (DA) and noradrenaline (NA) systems, originating from the VTA and LC respectively, show significant molecular and functional overlaps. Understanding these interactions is vital for treating neuropsychiatric conditions.
Area of Science:
- Neuroscience
- Neurochemistry
Background:
- Dopamine (DA) and noradrenaline (NA) are key neuromodulators influencing brain states, cognition, and behavior.
- The Ventral Tegmental Area (VTA) and Locus Coeruleus (LC) are traditionally viewed as distinct sources of DA and NA, respectively.
Purpose of the Study:
- To review the molecular, cellular, and physiological overlaps between DA and NA systems.
- To explore the functional implications of these catecholamine interactions.
- To highlight the importance of understanding these overlaps for neuropsychiatric interventions.
Main Methods:
- Comparative analysis of existing scientific literature.
- Review of studies on shared biosynthetic pathways, co-release, receptor/transporter non-specificity, and intracellular signaling.
- Examination of catecholamine innervation patterns and functional domains.
Main Results:
- DA and NA systems exhibit substantial overlaps, including shared synthesis, co-release from LC, convergent brain innervation, and similar signaling pathways.
- The Locus Coeruleus (LC) can release both NA and DA simultaneously across the brain.
- DA-NA interactions extend beyond the prefrontal cortex and hippocampus to the entire brain.
Conclusions:
- DA and NA may operate in parallel to support learning and maintain cognitive functions.
- Understanding the intricate interplay between DA and NA systems is crucial for developing effective therapeutics for neuropsychiatric disorders.
More Related Videos
07:56A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
06:40Combined Infusion and Stimulation with Fast-Scan Cyclic Voltammetry CIS-FSCV to Assess Ventral Tegmental Area Receptor Regulation of Phasic Dopamine
Published on: April 23, 2020
Related Concept Videos
Adrenergic Neurons: Neurotransmission
Synthesis: Catecholamine synthesis requires tyrosine, which...
Drugs Affecting Neurotransmitter Synthesis
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Drugs Affecting Neurotransmitter Release or Uptake
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Classification of Neurotransmitters